{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:09:41Z","timestamp":1785168581009,"version":"3.55.0"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T00:00:00Z","timestamp":1410220800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0107466","type":"journal-article","created":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T18:05:13Z","timestamp":1410285913000},"page":"e107466","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":109,"title":["Terlipressin versus Norepinephrine in the Treatment of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis"],"prefix":"10.1371","volume":"9","author":[{"given":"Antonio Paulo","family":"Nassar Junior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Queiroz","family":"Farias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Augusto Carneiro","family":"d\u2019 Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flair Jos\u00e9","family":"Carrilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Marcelo S\u00e1","family":"Malbouisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,9,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrneph.2011.96","article-title":"Management of hepatorenal syndrome in patients with cirrhosis","volume":"7","author":"V Arroyo","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jhep.2011.03.012","article-title":"Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice","volume":"55","author":"F Salerno","year":"2011","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1665-2681(19)31491-7","article-title":"Causes of renal failure in patients with decompensated cirrhosis and its impact in hospital mortality","volume":"11","author":"GC Carvalho","year":"2012","journal-title":"Ann Hepatol"},{"key":"ref4","first-page":"CD005162","article-title":"Terlipressin for hepatorenal syndrome","volume":"9","author":"LL Gluud","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study","volume":"36","author":"C Duvoux","year":"2002","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"A Liberati","year":"2009","journal-title":"BMJ"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"JP Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2288-9-80","article-title":"Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data","volume":"9","author":"BC Wallace","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"C Alessandria","year":"2007","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response","volume":"103","author":"P Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"V Singh","year":"2012","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/liv.12179","article-title":"Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study","volume":"33","author":"S Ghosh","year":"2013","journal-title":"Liver Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"V Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"ref14","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"F Salerno","year":"2007","journal-title":"Gut"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2012.06.024","article-title":"Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice","volume":"57","author":"P Angeli","year":"2012","journal-title":"J Hepatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"A Gines","year":"1993","journal-title":"Gastroenterology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1440-1746.2009.05873.x","article-title":"Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis","volume":"24","author":"Y Narahara","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/00365520310008728","article-title":"Effect of terlipressin on blood volume distribution in patients with cirrhosis","volume":"39","author":"M Kiszka-Kanowitz","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11255-010-9725-8","article-title":"Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis","volume":"43","author":"M Dobre","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/0253-7613.106436","article-title":"Survival benefits of terlipressin and non-responder state in hepatorenal syndrome: a meta-analysis","volume":"45","author":"SB Hiremath","year":"2013","journal-title":"Indian J Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"M Martin-Llahi","year":"2008","journal-title":"Gastroenterology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"A Nazar","year":"2010","journal-title":"Hepatology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"AJ Sanyal","year":"2008","journal-title":"Gastroenterology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0107466","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:01:48Z","timestamp":1589025708000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0107466"}},"subtitle":[],"editor":[{"given":"Helge","family":"Bruns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,9]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0107466","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,9]]}}}